Overview
ORKA market data
Price History
ORKA price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for ORKA. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
BTIG Reiterates Buy on Oruka Therapeutics, Maintains $151 Price TargetBenzinga · Jul 13, 2026, 10:34 AM
UBS Maintains Buy on Oruka Therapeutics, Raises Price Target to $130Benzinga · Jul 1, 2026, 4:20 PM
Oruka Therapeutics' Head of Finance Sold Over 10,000 Company Shares. What Does That Mean for Investors?The Motley Fool · Jun 24, 2026, 10:15 PM
Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On MondayBenzinga · Jun 22, 2026, 4:10 PM
Oruka Therapeutics Expands ORKA-001 License To All Indications, Adding Future IBD Rights Under Paragon AmendmentBenzinga · Jun 1, 2026, 8:11 PM
Oruka Therapeutics Q1 EPS $(0.48) Beats $(0.55) EstimateBenzinga · May 13, 2026, 8:49 PM
A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?The Motley Fool · May 11, 2026, 10:05 PM